The toad, and
the molecule.

One animal.
One molecule.

“Bufo” names a toad. “5-MeO-DMT” names a single compound found in its secretion.

The animal is the Sonoran Desert toad, classified today as Incilius alvarius and known for decades as Bufo alvarius. The older name is the one that stuck in common use, which is why most people searching for this subject type “Bufo”.

Its skin glands hold a secretion containing more than a dozen tryptamine compounds, among them bufotenin and 5-MeO-DMT. So the word names an animal, and by extension the substance taken from it. 5-MeO-DMT is one molecule within that mixture, and it can also be produced synthetically, without any toad.

Not two names
for one thing.

Toad secretion is not another name for purified 5-MeO-DMT.

The secretion contains other compounds alongside 5-MeO-DMT, including cardiotoxic ones, and how each contributes to an effect is not well understood. Its effects are not necessarily identical to those of the pure compound.

There is also no established relationship between an amount of secretion and the effect it produces, so the dose in any particular sample is not a known quantity. A study of a measured, manufactured formulation cannot be read as evidence about a biological secretion, and evidence about one preparation does not transfer to another.

A defined compound,
not a secretion.

AscentFive’s subject is 5-MeO-DMT as a defined synthetic compound. It is not a Bufo practice, and it does not work with toad secretion.

That is partly the question of what is actually in a substance, and partly a question about the animal. Toads are taken from their habitat to be milked, often not returned to where they were found, and sometimes handled cruelly. Poaching pressure and disrupted migration are documented conservation concerns.

Harm-reduction and conservation organisations reach the same conclusion for both reasons, and recommend synthetic 5-MeO-DMT over secretion taken from the animal.

Neither form
is without risk.

Choosing a defined compound removes an unknown. It does not remove risk.

Combining 5-MeO-DMT or bufotenin with a monoamine oxidase inhibitor — including the beta-carbolines found in some plant preparations — carries serious danger. A published case describes severe poisoning after such a combination, and deaths have been reported.

Reported adverse effects in clinical studies include nausea, vomiting and headache, and trial participants were selected healthy adults screened to exclude seizures, serious psychiatric concerns, pregnancy and MAOI use. Those exclusions describe who was studied; they are not a checklist anyone can clear themselves against. Personal health decisions need a qualified clinician who knows your full medication list and history.

A longer look at where this subject came from, and how it entered current research.